Sort   by:  
 Page size 
UnknownSystemic and targeted steroids for the treatment of IgA nephropathy.
Not available
S-EPMC10695509 | biostudies-literature
UnknownThe anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
Not available
S-EPMC10539216 | biostudies-literature
UnknownA previously unrecognized role of C3a in proteinuric progressive nephropathy.
Not available
S-EPMC4921969 | biostudies-literature
UnknownLow Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation.
Not available
S-EPMC9600228 | biostudies-literature
UnknownSirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage.
Not available
S-EPMC9368634 | biostudies-literature
UnknownMicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Not available
S-EPMC5423990 | biostudies-literature
UnknownManipulating Sirtuin 3 pathway ameliorates renal damage in experimental diabetes.
Not available
S-EPMC7242337 | biostudies-literature
UnknownShiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
Not available
S-EPMC4116050 | biostudies-literature
UnknownSGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.
Not available
S-EPMC6129124 | biostudies-literature
UnknownC3a receptor blockade protects podocytes from injury in diabetic nephropathy.
Not available
S-EPMC7141402 | biostudies-literature
Sort   by:  
 Page size